Company registration number SC160105 (Scotland)
MEDISCORE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MEDISCORE LIMITED
COMPANY INFORMATION
Director
Mrs H L Allan
Secretary
Mrs H L Allan
Company number
SC160105
Registered office
51 James Street
CARNOUSTIE
Scotland
DD7 7JY
Accountants
MMG Chartered Accountants
Chapelshade House
78-84 Bell Street
Dundee
Scotland
DD1 1RQ
MEDISCORE LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 8
MEDISCORE LIMITED
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ACCOUNTS OF MEDISCORE LIMITED
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Mediscore Limited for the year ended 31 March 2025 set out on pages 2 to 8 from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants of Scotland we are subject to its ethical and other professional requirements which are detailed at https://icas.com/icas-framework-preparation-of-accounts.

This report is made solely to the Board of Directors of Mediscore Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Mediscore Limited and state those matters that we have agreed to state to the Board of Directors of Mediscore Limited, as a body, in this report in accordance with the requirements of the ICAS as detailed at https://icas.com/icas-framework-preparation-of-accounts. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Mediscore Limited and its Board of Directors as a body, for our work or for this report.

It is your duty to ensure that Mediscore Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Mediscore Limited. You consider that Mediscore Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Mediscore Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

MMG Chartered Accountants
Chapelshade House
78-84 Bell Street
Dundee
DD1 1RQ
Scotland
12 December 2025
MEDISCORE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
3,343
3,567
Investment property
5
263,987
263,987
267,330
267,554
Current assets
Debtors
6
-
0
155
Cash at bank and in hand
555
550
555
705
Creditors: amounts falling due within one year
7
(59,915)
(54,962)
Net current liabilities
(59,360)
(54,257)
Total assets less current liabilities
207,970
213,297
Creditors: amounts falling due after more than one year
8
(82,732)
(90,412)
Provisions for liabilities
(5,133)
(5,133)
Net assets
120,105
117,752
Capital and reserves
Called up share capital
2
2
Other reserves
56,010
55,958
Profit and loss reserves
64,093
61,792
Total equity
120,105
117,752
MEDISCORE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 3 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 12 December 2025
Mrs H L Allan
Director
Company registration number SC160105 (Scotland)
MEDISCORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
1
Accounting policies
Company information

Mediscore Limited is a private company limited by shares incorporated in Scotland. The registered office is 51 James St, Carnoustie, Scotland.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

1.4
Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. Plant and machinery etc - 20% on cost

Leasehold improvements
20% on cost
Fixtures and fittings
20% on cost
1.5
Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

MEDISCORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

MEDISCORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
4
Tangible fixed assets
Leasehold improvements
Fixtures and fittings
Total
£
£
£
Cost
At 1 April 2024
5,540
8,182
13,722
Disposals
-
0
(5,576)
(5,576)
At 31 March 2025
5,540
2,606
8,146
Depreciation and impairment
At 1 April 2024
2,212
7,943
10,155
Depreciation charged in the year
165
59
224
Eliminated in respect of disposals
-
0
(5,576)
(5,576)
At 31 March 2025
2,377
2,426
4,803
MEDISCORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
4
Tangible fixed assets
Leasehold improvements
Fixtures and fittings
Total
£
£
£
(Continued)
- 7 -
Carrying amount
At 31 March 2025
3,163
180
3,343
At 31 March 2024
3,328
239
3,567
5
Investment property
2025
£
Fair value
At 1 April 2024 and 31 March 2025
263,987

Investment property comprises various residential properties. The fair value of the investment property has been arrived at on the basis of a valuation carried out at the year end by the director. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties.

6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
155
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
6,912
4,088
Trade creditors
1,345
-
0
Corporation tax
-
0
868
Other creditors
51,658
50,006
59,915
54,962

Bank borrowings are secured by way of standard securities over specific properties owned by the company and by a bond and floating charge over all assets of the company.

8
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
82,732
90,412
MEDISCORE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
9
Related party transactions
2025
2024
Amounts due to related parties
£
£
Key management personnel
49,917
47,723
2025-03-312024-04-01falsefalsefalse12 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMrs H L AllanMrs H L AllanSC1601052024-04-012025-03-31SC160105bus:CompanySecretaryDirector12024-04-012025-03-31SC160105bus:CompanySecretary12024-04-012025-03-31SC160105bus:Director12024-04-012025-03-31SC160105bus:RegisteredOffice2024-04-012025-03-31SC1601052025-03-31SC1601052024-03-31SC160105core:LeaseholdImprovements2025-03-31SC160105core:FurnitureFittings2025-03-31SC160105core:LeaseholdImprovements2024-03-31SC160105core:FurnitureFittings2024-03-31SC160105core:WithinOneYear2025-03-31SC160105core:WithinOneYear2024-03-31SC160105core:AfterOneYear2025-03-31SC160105core:AfterOneYear2024-03-31SC160105core:CurrentFinancialInstruments2025-03-31SC160105core:CurrentFinancialInstruments2024-03-31SC160105core:ShareCapital2025-03-31SC160105core:ShareCapital2024-03-31SC160105core:OtherMiscellaneousReserve2025-03-31SC160105core:OtherMiscellaneousReserve2024-03-31SC160105core:RetainedEarningsAccumulatedLosses2025-03-31SC160105core:RetainedEarningsAccumulatedLosses2024-03-31SC160105core:LeaseholdImprovements2024-04-012025-03-31SC160105core:FurnitureFittings2024-04-012025-03-31SC1601052023-04-012024-03-31SC160105core:LeaseholdImprovements2024-03-31SC160105core:FurnitureFittings2024-03-31SC1601052024-03-31SC160105core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-31SC160105core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-31SC160105core:Non-currentFinancialInstruments2025-03-31SC160105core:Non-currentFinancialInstruments2024-03-31SC160105bus:PrivateLimitedCompanyLtd2024-04-012025-03-31SC160105bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-31SC160105bus:FRS1022024-04-012025-03-31SC160105bus:AuditExemptWithAccountantsReport2024-04-012025-03-31SC160105bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP